Sarepta Therapeutics (SRPT) PT Raised to $5 at H.C. Wainwright
Tweet Send to a Friend
H.C. Wainwright analyst Mitchell S. Kapoor raised the price target on Sarepta Therapeutics (NASDAQ: SRPT) to $5.00 (from $0) while ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
